VBI Vaccines Inc/BC Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
VBI Vaccines Inc/BC quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2015 to Q1 2024.
  • VBI Vaccines Inc/BC Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$600M, a 16% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$600M -$83M -16% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$582M -$92.8M -19% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 -$582M -$114M -24.3% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$562M -$119M -26.8% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$517M -$120M -30.1% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$490M -$111M -29.4% Dec 31, 2022 10-K 2024-04-16
Q3 2022 -$468M -$109M -30.3% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 -$443M -$99.5M -29% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 -$398M -$71.3M -21.9% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 -$378M -$69.8M -22.6% Dec 31, 2021 10-K 2023-03-13
Q3 2021 -$360M -$66.3M -22.6% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 -$344M -$63.5M -22.7% Jun 30, 2021 10-Q 2021-08-02
Q1 2021 -$326M -$55.5M -20.5% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 -$309M -$46.2M -17.6% Dec 31, 2020 10-K 2022-03-07
Q3 2020 -$293M -$41.7M -16.6% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 -$280M -$44.9M -19.1% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 -$271M -$48.6M -21.9% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 -$262M -$54.8M -26.4% Dec 31, 2019 10-K 2021-03-02
Q3 2019 -$252M -$63.2M -33.6% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 -$235M -$62.4M -36.1% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 -$222M -$66M -42.2% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 -$208M -$63.6M -44.2% Dec 31, 2018 10-K 2020-03-05
Q3 2018 -$188M -$55.9M -42.2% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 -$173M -$50.3M -41% Jun 30, 2018 10-Q 2018-07-26
Q1 2018 -$156M -$42.6M -37.5% Mar 31, 2018 10-Q 2018-05-01
Q4 2017 -$144M -$39M -37.1% Dec 31, 2017 10-K 2019-02-25
Q3 2017 -$132M Sep 30, 2017 10-Q 2017-11-13
Q2 2017 -$123M Jun 30, 2017 10-Q 2017-07-31
Q1 2017 -$114M Mar 31, 2017 10-Q 2017-05-15
Q4 2016 -$105M -$23.2M -28.4% Dec 31, 2016 10-K 2018-02-26
Q4 2015 -$81.8M Dec 31, 2015 10-K 2017-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.